Inflammatory Biomarkers of Asymptomatic and Symptomatic Tuberculosis
Awany, D.; Ariefdien, D.; Mendelsohn, S.; Rozot, V.; Mulenga, H.; Nyangu, S.; Tameris, M.; Moloantoa, T.; Katona, A.; Maruri, F.; Noor, F.; Panchiar, R.; Hlongwane, K.; Stanley, K.; Van der Heijden, Y.; Hadley, K.; Fiore-Gartland, A.; Innes, C.; Brumskine, W.; Dheda, K.; Jaumdally, S.; Perumal, T.; Martinson, N.; Leslie, A.; Fourie, B.; Hiemstra, A.; Malherbe, S.; Walzl, G.; Naidoo, K.; Churchyard, G.; Chegou, N.; Sterling, T.; Hatherill, M.; Scriba, T. J.
Show abstract
A large proportion of individuals with tuberculosis (TB) are asymptomatic. The biological and inflammatory underpinnings of asymptomatic TB are unknown and may differ from symptomatic TB. We characterised blood transcriptomic and proteomic profiles in South African community screening vs. health facility-based triage cohorts. Asymptomatic TB shared core transcriptomic and proteomic features with symptomatic TB, including upregulation of innate, interferon and inflammatory pathways and downregulation of T and B cell pathways. Integration of transcriptomic and proteomic data from asymptomatic TB individuals identified two distinct sub-clusters characterized by higher or lower bacterial burden, blood IFN-{gamma} responses, BMI, and chest radiographic abnormalities, suggesting different disease severity. We identified a new blood transcriptomic signature of asymptomatic TB. However, diagnostic performance of transcriptomic and proteomic markers was weaker for asymptomatic TB than symptomatic TB, suggesting that policy development for community-based, asymptomatic TB screening should not adopt biomarkers developed for symptomatic TB triage without further optimization.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Circulating Cell-Free RNA in Blood as a Host Response Biomarker for the Detection of Tuberculosis 97%
- Elevated mucosal antibody responses against SARS-CoV-2 are correlated with lower viral load and faster decrease in systemic COVID-19 symptoms 94%
- A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region 94%
Similar papers in this journal
Similar papers in this journal
- Comparative transcriptomic analysis of whole blood mycobacterial growth assays and tuberculosis patients' blood RNA profiles 95%
- Blood RNA Signatures Predict Recent Tuberculosis Exposure in Mice, Macaques and Humans 94%
- A needle in a haystack: metagenomic DNA sequencing to quantify Mycobacterium tuberculosis DNA and diagnose tuberculosis 94%
Similar papers in this journal
- Mast cells promote pathology and susceptibility in tuberculosis 94%
- Plasmodium falciparum adapts its investment into replication versus transmission according to the host environment 93%
- Soluble immune mediators orchestrate protective in vitro granulomatous responses across Mycobacterium tuberculosis complex lineages 93%
Similar papers in this journal
- Non-severe SARS-CoV-2 infection is characterised by very early T cell proliferation independent of type 1 interferon responses and distinct from other acute respiratory viruses 94%
- Rewired type I IFN signaling is linked to age-dependent differences in COVID-19 92%
- Antibody therapy reverses biological signatures of COVID-19 progression 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.